针刺治疗子宫内膜异位症相关疼痛的疗效:一项多中心随机单盲安慰剂对照试验
该多中心随机单盲安慰剂对照试验纳入106例子宫内膜异位症相关疼痛女性,比较针刺与假针刺治疗12周并随访12周。针刺组痛经VAS评分下降在治疗结束时显著大于假针刺组,但试验结束时无显著差异;针刺组疼痛持续时间显著缩短,第12周各项量表评分改善显著优于假针刺组,第24周无显著差异。无严重不良事件。
要点
- 针刺可有效缓解子宫内膜异位症相关痛经并缩短疼痛持续时间。
- 针刺改善健康状况与生活质量,但疗效在停止治疗后减退。
- 针刺未显著改善非经期盆腔痛和性交痛,无严重不良事件。
核心结论
- 针刺是缓解子宫内膜异位症相关疼痛女性痛经、缩短疼痛持续时间及改善健康状况与生活质量的有效且安全的方法,但其疗效在停止治疗后减退。
研究设计与样本
- 多中心、随机、单盲、安慰剂对照试验,在江西省和海南省的四家三级医院开展。
- 共106名20至40岁子宫内膜异位症相关疼痛女性随机分配至针刺组和假针刺组。
- 干预12周,从每次预期月经前一周开始,每日一次30分钟,每周3次;月经期出现子宫内膜异位症相关盆腔痛时每日针刺;治疗后随访12周。
主要发现
- 针刺组痛经VAS评分下降在治疗后显著大于假针刺组,但试验结束时两组无显著差异。
- 针刺组疼痛持续时间显著短于假针刺组。
- 第12周时针刺组所有测试评分改善程度显著大于假针刺组,但第24周时无显著差异。
- 非经期盆腔痛和性交痛VAS评分变化两组间无差异。
- 未记录严重不良事件,不良事件两组间无差异。
临床怎么用
- 作者认为针刺是缓解子宫内膜异位症相关痛经、缩短疼痛持续时间及改善健康状况与生活质量的有效且安全的方法,但疗效在停止治疗后减退。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the efficacy and safety of acupuncture in the treatment of endometriosis-associated pain. DESIGN: A multicenter, randomized, single-blind, placebo-controlled trial. INSTITUTIONS: Four tertiary hospitals in Jiangxi and Hainan Provinces. SUBJECTS: Women with endometriosis-associated pain aged between 20 and 40 years. INTERVENTION: Subjects were assigned randomly to receive either acupuncture or sham acupuncture treatment for 12 weeks, starting one week before each expected menstruation and administered as a 30-minute session once per day, 3 times a week. During the menstruation period, acupuncture was administered daily when pelvic pain associated with endometriosis occurred. After acupuncture or sham acupuncture treatment, the subjects were followed for another 12 weeks. MAIN OUTCOME MEASURES: Changes in maximum pain as assessed with the visual analog scale (VAS) for various pelvic pain, duration of dysmenorrhea, and scores on the Multidimensional Pain Inventory, Beck Depression Inventory, Profile of Mood States, and Endometriosis Health Profile from baseline to week 12 and week 24. RESULTS: A total of 106 women were assigned randomly to the acupuncture and sham groups. In the acupuncture group, the reduction in the dysmenorrhea VAS score was significantly greater after treatment, but not at the end of the trial, compared to the sham group. The duration of pain was significantly shorter in the acupuncture group. All test scores were improved to a significantly greater extent in the acupuncture group than in the sham group at week 12 but not at week 24. Changes in nonmenstrual pelvic pain and dyspareunia VAS scores were not different between the groups. No severe adverse events or differences in adverse events were recorded. CONCLUSION: Acupuncture is an effective and safe method of relieving dysmenorrhea, shortening the pain duration, and improving wellbeing and quality of life in women with endometriosis-associated pain, although its efficacy fades after treatment is discontinued. CLINICAL TRIAL REGISTRATION NUMBER: NCT03125304.
引用
- Li PS, Peng XM, Niu XX, et al. Efficacy of acupuncture for endometriosis-associated pain: a multicenter randomized single-blind placebo-controlled trial. Fertil Steril. 2023. PMID: 36716811. doi:10.1016/j.fertnstert.2023.01.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。